Hélène Albrand
Hélène Albrand publishes mostly in Oncology, Immunology and Hematology, on topics such as Biosimilars and Bioanalytical Methods, Neutropenia and Cancer Infections and Erythropoietin and Anemia Treatment.
- World rank
- #6,271,610 of 7,710,434 ranked researchers
- Rank in France
- #268,008 of 324,115
- Works
- 32
- Citations
- 64
- Citations per work
- 2.0
What does Hélène Albrand research?
Hélène Albrand's work is mostly in Medicine (61%), Immunology and Microbiology (28%), Biochemistry, Genetics and Molecular Biology (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1960.9%
- Medicine1960.9%
- Life Sciences1133.7%
- Social Sciences13.3%
- Everything else12.1%
- 1Oncology41% of their works
- 2Immunology28% of their works
- 3Hematology16% of their works
- 4Genetics5% of their works
- 5Economics and Econometrics3% of their works
- 6Biochemistry3% of their works
Research topics
Which keywords describe Hélène Albrand's research?
The keywords of their largest research topics: Clinical Outcomes, Biosimilars, Immunogenicity, Chemotherapy, Antimicrobial Agents, Febrile Neutropenia, Anemia and Neuroprotection.
- Thrombolysis
- KRAS Mutations
- Hemorrhage
- Neutropenia
- Taxanes
- Chronic Kidney Disease
- Neuroprotection
- Febrile Neutropenia
- Chemotherapy
- Biosimilars
- Clinical Outcomes
- Immunogenicity
- Antimicrobial Agents
- Anemia
- Chemotherapy-Induced Peripheral Neuropathy
- Heart Failure
- Genetic Mutations
- Blood Transfusion
- Cetuximab
- Ischemic Stroke
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 20 words, with their numbers
- Clinical Outcomes272 topics
- Biosimilars261 topic
- Immunogenicity261 topic
- Chemotherapy242 topics
- Antimicrobial Agents221 topic
- Febrile Neutropenia221 topic
- Anemia172 topics
- Neuroprotection152 topics
- Chemotherapy-Induced Peripheral Neuropathy141 topic
- Chronic Kidney Disease141 topic
- Heart Failure141 topic
- Taxanes141 topic
- Genetic Mutations51 topic
- Neutropenia51 topic
- Blood Transfusion31 topic
- Hemorrhage31 topic
- Cetuximab21 topic
- KRAS Mutations21 topic
- Ischemic Stroke11 topic
- Thrombolysis11 topic
Where does Hélène Albrand work?
Hélène Albrand's main affiliation in the publication record is Centre Hospitalier Régional Universitaire de Brest, France.
How many publications and citations does Hélène Albrand have?
OpenAlex counts 32 works and 64 citations for Hélène Albrand, an h-index of 3, ranking #6,271,610 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Hélène Albrand. Posts are plain text and can be reported.